Gastrointestinal (GI) conditions are common in neonates and infants. These may include Gastroesophageal Reflux (GER), ...
Experiments in three therapeutic cancer vaccine mouse models, conducted by investigators at the Vaccine Branch of the National Cancer Institute in Bethesda, Maryland, support the conclusion that ...
Results, presented at ObesityWeek® 2025, showed patients receiving NG101 saw 40% reduction in nausea incidence and 67% ...
Sparsentan therapy was associated with sustained decline in proteinuria and lower likelihood of progression to kidney failure ...
Type 1 diabetes with CKD is understudied with no advancement of therapy options since the 1990s. The FINE-ONE phase 3 trial addresses a high, unmet need for treatments.
Insilico announced the launch of its innovative cardiometabolic disease portfolio of unique highly-differentiated molecules ...
October 2025 saw a wave of M&As and biotech deals in various therapeutic fields, particularly for therapies addressing ...
Sana Biotechnology, CAMP4 Therapeutics and Crinetics Pharmaceuticals have all used the third quarter to refocus their ...
Blocking progesterone receptor (PR) activity has long been viewed as a possible approach to breast cancer prevention. Historically, most supporting evidence came from animal models, epidemiological ...
The shadow of Alzheimer's disease looms large over our aging population. It is more than a memory disorder; it's a humanitarian, social, and economic crisis. Accounting for nearly 80 percent of all ...
Activates innate and adaptive immune pathways, including increased antigen-experienced CD8 + T cells, activated CD4 + T cells, and Ki67 + NK cells. Induces immune-regulating chemokines CXCL9 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback